Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fcvm.2022.953211
PubMed Identifier: 36299872
Publication URI: http://europepmc.org/abstract/MED/36299872
Type: Journal Article/Review
Parent Publication: Frontiers in Cardiovascular Medicine
ISSN: 2297-055X